SFX by Ex Libris Inc.

Title:	High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Source:	Nature [0028-0836] Kleinstiver, B P yr:2016

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Heidenreich, M. "Applications of CRISPR-Cas systems in neuroscience." Nature reviews. Neuroscience 17.1 (2015): 36-44.
description	2.	Quetier, F. "The CRISPR-Cas9 technology: Closer to the ultimate toolkit for targeted genome editing." Plant science 242.Sp. Iss. SI (2016): 65-76.
description	3.	Doudna, Jennifer A. "Genome-editing revolution: My whirlwind year with CRISPR." Nature 528.7583 (2015): 469-471.
description	4.	Cech, Thomas R. "A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression." Genome biology 16.1 (2015): 231-231.
description	5.	Wickens, J. "Toward an Anatomy of Disappointment: Reward-Related Signals from the Globus Pallidus." Neuron 60.4 (2008): 530-1.
description	6.	Lee, Han B. "Genome Engineering with TALE and CRISPR Systems in Neuroscience." Frontiers in genetics 7 (2016): 47-47.
description	7.	Doudna, Jennifer A. "The new frontier of genome engineering with CRISPR-Cas9." Science 346.6213 (2014): 96-1258096.
description	8.	Hart, T. "High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities." Cell 163.6 (2015): 1515-1526.
description	9.	Charpentier, E. "A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity." Science 337.6096 (2012): 816-820.
description	10.	Baumann, M. "CRISPR/Cas9 genome editing – new and old ethical issues arising from a revolutionary technology." NanoEthics 10.2 (2016): 139-159.
description	11.	Mei, Y. "Review: Recent progress in CRISPR/Cas9 technology." Journal of Genetics and Genomics 43.2 (2016): 63-75.
description	12.	Du, H. "Efficient targeted mutagenesis in soybean by TALENs and CRISPR/Cas9." Journal of biotechnology 217.C (2016): 90-97.
description	13.	Doudna, J. "My whirlwind year with CRISPR." Nature 528.7583 (2015): 469-471.
description	14.	Kirchner, M. "CRISPR-Cas: From the Bacterial Adaptive Immune System to a Versatile Tool for Genome Engineering." Angewandte Chemie (International ed.) 54.46 (2015): 13508-13514.
description	15.	OGeen, H. "How specific is CRISPR/Cas9 really?" Current opinion in chemical biology 29 (2015): 72-78.
description	16.	Lisowski, P. "Epigenetics of stress adaptations in the brain." Brain research bulletin 98.C (2013): 76-92.
description	17.	Underkoffler, Lara A. "Transmission ratio distortion in offspring of mouse heterozygous carriers of a (7.18) Robertsonian translocation." Genetics 169.2 (2005): 843-8.
description	18.	Waehler, R. "Engineering targeted viral vectors for gene therapy." Nature reviews. Genetics 8.8 (2007): 573-87.
description	19.	Charpentier, E. "Rewriting a genome." Nature 495.7439 (2013): 50-51.
description	20.	van Deutekom, J C C. "Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells." Human Molecular Genetics 10.15 (2001): 1547-54.